Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study by Cruijsen, M., van der Velden, W.J.F.M, de Haan, A.F.J., Klein, S. K., Hoogendoorn, M., Tromp, Y., de Valk, B., van Rees, B., de Boer, F., van der Spek, E., Pruijt, J., Verdonck, L.F., Vellenga, E., Blijlevens, N., van de Loosdrecht, A. A., Huls, G.

Get full text

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER... by Tryfonidis, Konstantinos, Marreaud, S., Khaled, H., De Valk, B., Vermorken, J., Welnicka-Jaskiewicz, M., Aalders, K., Bartlett, J. M. S., Biganzoli, L., Bogaerts, J., Cameron, David

Get full text

Alveolar soft-part sarcoma responding to interferon alpha-2b by Roozendaal, K J, de Valk, B, ten Velden, J J A, van der Woude, H J, Kroon, B B R

Get full text

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally... by Bahadoer, Renu R, Dijkstra, Esmée A, van Etten, Boudewijn, Marijnen, Corrie A M, Putter, Hein, Kranenbarg, Elma Meershoek-Klein, Nagtegaal, Iris D, Beets-Tan, Regina G H, Blomqvist, Lennart K, Fokstuen, Tone, Capdevila, Jaume, Cervantes, Andrés, Glimelius, Bengt, Østergaard, L., Svendsen Jensen, F., Pfeiffer, P., Jensen, K.E.J., Schreurs, W.H., van der Vliet, J.J., Bruynzeel, A.M.E., Kerver, E.D., van Leerdam, M.E., Tanis, P.J., Bleeker, W.A., Ten Tije, A.J., Immink, J.M., Marinelli, A.W.K.S., Ceha, H.M., Bekker, J.H.M., Creemers, G.J., Nieuwenhuijzen, G.A.P., van den Berg, H., van der Deure, W.M., Olieman, A.F.T., van den Bergh, A.C.M., de Groot, D.J.A., Havenga, K., Beukema, J.C., Vanstiphout, J.W.P., de Valk, B., Eijsbouts, Q.A.J., Polée, M.B., Hoff, C., Peters, F.P., Radema, S.A., de Wilt, H., Braam, P., Veldhuis, G.J., Hess, D., Rozema, T., Reerink, O., Pronk, A., Vos, J., Tascilar, M., Patijn, G.A., Kersten, C., Mjåland, O., Nesbakken, A.N., Benedik, J., Velenik, V., Capdevila, J., Espin, E., Salazar, R., Biondo, S., die Trill, J., Aparicio, J., Garcia Granero, E., Safont, M.J., Cervantes, A., Espí Macías, A., Malmberg, L., Dafnis, G., Berglund, A., Österlund, L., Kovacs, K., Hol, J., Ottosson, S., Carlsson, G., Bratthäll, C., Assarsson, J., Lödén, B.L., Hede, P., Verbiené, I., Hallböök, O., Johnsson, A., Lydrup, M.L., Villmann, K., Matthiessen, P., Haux, J., Skullman, S., Holm, T., Flygare, P., Walldén, M., Lundberg, O., Radu, C., Påhlman, L., Palenius, U., Parinkh, P., Kim, H., Silviera, M.L.

Get full text

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials by Vergote, Ignace, Coens, Corneel, Nankivell, Matthew, Kristensen, Gunnar B, Parmar, Mahesh K B, Jayson, Gordon C, Swart, Ann Marie, Verheijen, René, McCluggage, W Glenn, Perren, Tim, Panici, Pierluigi Benedetti, Kenter, Gemma, Casado, Antonio, Mendiola, Cesar, Stuart, Gavin, Reed, Nick S, Kehoe, Sean, Tropé G., Claes, Dobbs, Stephen, Essapen, Sharadah, Hoskins, P., Van Baal, M., Twigg, Jeremy, Van Der Burg, Maria E.L., Godfrey, Keith, Lacave, Angel J., Redman, Charles, Lotocki, R., Olaitan, Adeola, Mosgaard, B., Rustin, G., Persic, Mojca, Hogg, Martin, Van Der Velden, J., Ledermann, J., Peter Sykes, Peter Sykes, Hird, Vicky, Sandvei R., R., Cruickshank, D.J., Ottevanger, P.B., Pearson, Sheila, Hall, Marcia, Bessette, P., Gerdin, E., Lopes, Tito, Fish, Andrew, Van Eygen, K., Floquet, A., Tholander, B., Gul, N., Gornall, Robert, Luesley, David, Symonds, Paul, Poole, David, McNeish, Ian, Hocking, Mark, Sammaraie, Al, Speiser, P., Leblanc, E., De Oliveira, C.F., Grimshaw, R., Zola, P., Parkin, David, Lamb, Martin, Gillespie, Alan, Hamid, Abdel, Ahmed, Ahmed, Perez, David, Skailes, Geraldine, Jones, Rachel, Leeson, Simon, Elit, L., Gotlieb, W., Crosse, Barbara, Ridley, Paul, Head, Anthony, Nieto, Joaquin, Awwad, Saif, Brinkmann, Dirk, Eustace, Damian, Katsaros, D., Popadiuk, C., Redman, C., Chan, S., Marth, C., Lankaster, Kate, Indrajit, Fernando, Quigley, Mary, Adeyemi, Olu, McNally, Orla, Tristam, Amanda, Lee, Martin, Counsell, R., Gleeson, N., Papadopoulos, A., Maggino, T., Ghatage, P., Vermorken, J.B., Petru, E, Amant, F.

Get full text

Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes by DE VALK, B, ADDICKS, M. A, GOSRIWATANA, I, LU, S, HIDER, R. C, MARX, J. J. M

Get full text

Biochemical expression of heterozygous hereditary hemochromatosis by de Valk, B, Witlox, R.S.G.M, van der Schouw, Y.T, Marx, J.J.M

Get full text

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patient... by Sanz, Miguel A., Montesinos, Pau, Rayón, Chelo, Holowiecka, Alexandra, de la Serna, Javier, Milone, Gustavo, de Lisa, Elena, Brunet, Salut, Rubio, Vicente, Ribera, José M., Rivas, Concha, Krsnik, Isabel, Bergua, Juan, González, José, Díaz-Mediavilla, Joaquín, Rojas, Rafael, Manso, Félix, Ossenkoppele, Gert, González, José D., Lowenberg, Bob

Get full text

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine by Pabst, Thomas, Vellenga, Edo, van Putten, Wim, Schouten, Harry C., Graux, Carlos, Vekemans, Marie-Christiane, Biemond, Bart, Sonneveld, Peter, Passweg, Jakob, Verdonck, Leo, Legdeur, Marie-Cecile, Theobald, Matthias, Jacky, Emanuel, Bargetzi, Mario, Maertens, Johan, Ossenkoppele, Gert Jan, Löwenberg, Bob

Get full text

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens by Montesinos, Pau, Rayón, Chelo, Vellenga, Edo, Brunet, Salut, González, José, González, Marcos, Holowiecka, Aleksandra, Esteve, Jordi, Bergua, Juan, González, José D., Rivas, Concha, Tormo, Mar, Rubio, Vicente, Bueno, Javier, Manso, Félix, Milone, Gustavo, de la Serna, Javier, Pérez, Inmaculada, Pérez-Encinas, Manuel, Krsnik, Isabel, Ribera, Josep M., Escoda, Lourdes, Lowenberg, Bob, Sanz, Miguel A.

Get full text

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study by Löwenberg, Bob, Beck, Joachim, Graux, Carlos, van Putten, Wim, Schouten, Harry C., Verdonck, Leo F., Ferrant, Augustin, Sonneveld, Pieter, Jongen-Lavrencic, Mojca, von Lilienfeld-Toal, Marie, Biemond, Bart J., Vellenga, Edo, Breems, Dimitri, de Muijnck, Hilde, Schaafsma, Ron, Verhoef, Gregor, Döhner, Hartmut, Gratwohl, Alois, Pabst, Thomas, Ossenkoppele, Gert J., Maertens, Johan, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), German Austrian AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)

Get full text

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy by Greimel, Elfriede, Kristensen, Gunnar B, van der Burg, Maria E.L, Coronado, Pluvio, Rustin, Gordon, del Rio, Angel Sanchez, Reed, Nicholas S, Nordal, Randi R, Coens, Corneel, Vergote, Ignace

Get full text

UGT1A128 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study by Kweekel, D M, Gelderblom, H, Van der Straaten, T, Antonini, N F, Punt, C J A, Guchelaar, H-J

Get full text

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy by BARRAGAN, Eva, MONTESINOS, Pau, COLOMER, Dolors, CHILLON, Carmen, LARRAYOZ, Maria J, SANCHEZ-GODOY, Pedro, GONZALEZ-CAMPOS, José, MANSO, Félix, AMADOR, Maria L, VELLENGA, Edo, LOWENBERG, Bob, SANZ, Miguel A, CAMOS, Mireia, GONZALEZ, Marcos, CALASANZ, Maria J, ROMAN-GOMEZ, Jose, GOMEZ-CASARES, Maria T, AYALA, Rosa, LOPEZ, Javier, FUSTER, Oscar

Get full text

Iron does not bind to the Apo-B protein of low-density lipoprotein by De Valk, B., Leus, F. R., Voorbij, H. A. M., Marx, J. J. M.

Get full text

2122 POSTER Efficacy of combined Trastuzumab and CMF therapy in women with metastatic breast cancer. EORTC protocol 10995 by Neskovic-Konstantinovic, Z, Nooij, M, Khaled, H, De Valk, B, Vermorken, J, Welnicka-Jaskiewicz, M, Piccart, M, Marreaud, S, Bogaerts, J, Cameron, D

Get full text

Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women by ROEST, M, VAN DER SCHOUW, Y. T, DE VALK, B, MARX, J. J. M, TEMPELMAN, M. J, DE GROOT, P. G, SIXMA, J. J, BANGA, J. D

Get full text

P87 Breast cancer presenting as gastric signet ring cell carcinoma by Warmerdam, F.A.R.M., de Valk, B., Blaauwgeers, J.L.G., Roozendaal, K.J.

Get full text

Iron does not bing to the Apo-B protein of low-density lipoprotein by de Valk, B, Leus, F R, Voorbij, H A M, Marx, J J M

Get full text

Low incidence of cardiac events in an EORTC phase II study of CMF in combination with trastuzumab in women with HER-2 positive metastatic breast cancer by Cameron, D., Marreaud, S., Neskovic-Konstantinovic, Z., Omar, S., Nooij, M., De Valk, B., Bogaerts, J., Therasse, P.

Get full text